Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes

Author
S Mannering, F Wong, I Durinovic-Belló, B Brooks-Worrell, T Tree, C Cilio, N Schloot, R Mallone, Immunology Committee
Abstract

Type 1 diabetes (T1D) is an autoimmune disease caused by the T cell-mediated destruction of the pancreatic insulin-producing beta cells. Currently there are no widely accepted and standardized assays available to analyse the function of autoreactive T cells involved in T1D. The development of such an assay would greatly aid efforts to understand the pathogenesis of T1D and is also urgently required to guide the development of antigen-based therapies intended to prevent, or cure, T1D. Here we describe some of the assays used currently to detect autoreactive T cells in human blood and review critically their strengths and weaknesses. The challenges and future prospects for the T cell assays are discussed.

Year of Publication
2010
Journal
Clinical and experimental immunology
Volume
162
Issue
2
Number of Pages
197-209
Date Published
11/2010
ISSN Number
1365-2249
DOI
10.1111/j.1365-2249.2010.04237.x
Alternate Journal
Clin Exp Immunol
PMCID
PMC2996587
PMID
20846160
Download citation
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ